Sangamo Therapeutics (GBY.F) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.25
-0.23
-0.22
-0.2

Details

Expected EPS
-0.198189
Actual EPS
-0.250344
Surprise EPS
-0.05
Surprise Percent
+26.32%

Description

Sangamo Therapeutics (GBY.F) has reported earnings of -0.250344 per share for Q2 2024.

0 Comments

Share your thoughts